用denosumab治疗的儿科患者的甲基细胞带骨折
Rodrigo Montero-Lopez1,2, Karissa Ludwig3,4, Benjamin Jacobs5
1Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, 4021 Linz, Austria.
European journal of endocrinology
|November 10, 2025
概括
服用德诺苏马布的儿科患者可能会在硬化性甲基细胞带中发生骨折,这通常与反弹性高热血症有关. 骨科专家对儿童进行密切监测,这在代诺苏马布治疗期间至关重要.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 儿科整形外科 儿科整形外科
- 骨生物学 骨生物学 骨生物学
背景情况:
- 丹诺苏马布是一种RANKL抑制剂,用于儿童骨疾病的非标签治疗.
- 人们担心denosumab对骨建模和重塑的影响,以及反弹高血症的影响.
- 甲基细胞硬化带是治疗德诺苏马布的儿童骨折的潜在地点.
研究的目的:
- 用denosumab治疗的儿科患者中形容甲基细胞硬化带骨折的临床,生化和放射性特征.
- 评估这些骨折的风险因素,重点关注反弹高血症的时间和发生.
主要方法:
- 追溯多中心研究.
- 对临床,生化和X射线数据的审查.
- 高分辨率的外围定量计算断层扫描 (HR-pQCT) 和微有限元分析在一个案例中.
主要成果:
- 五名儿科患者 (7-18岁) 经历了1.5-7.7年的denosumab治疗后,在甲基细胞硬化带中发生骨折.
- 所有患者都患有反弹性高血症,往往会发生骨折.
- HR-pQCT显示骨密度和硬度增加,但硬化带的故障负载减少.
结论:
- 通过甲基细胞硬化带的骨折可能是denosumab在儿童中的特定并发症.
- 反弹性高血症和骨折可以同时发生.
- 儿科骨专家必须密切监测儿童在denosumab治疗期间.
关键词:
兰克尔 (Rankl) 是一个名字.抗吸收疗法是一种抗吸收疗法.骨头周转率反弹的反弹这里没有denosumab.骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折,骨折.儿科骨疾病儿童骨疾病更多相关视频
06:53A Rat Tibial Growth Plate Injury Model to Characterize Repair Mechanisms and Evaluate Growth Plate Regeneration Strategies
Published on: July 4, 2017
11.5K
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
8.6K
相关概念视频
Fractures: Bone Repair
4.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
4.9K
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
